142 related articles for article (PubMed ID: 19172164)
1. PML: a tumor suppressor essential for neocortical development.
Schreck KC; Gaiano N
Nat Neurosci; 2009 Feb; 12(2):108-10. PubMed ID: 19172164
[No Abstract] [Full Text] [Related]
2. The tumor suppressor Pml regulates cell fate in the developing neocortex.
Regad T; Bellodi C; Nicotera P; Salomoni P
Nat Neurosci; 2009 Feb; 12(2):132-40. PubMed ID: 19136970
[TBL] [Abstract][Full Text] [Related]
3. Regulation of apoptosis by PML and the PML-NBs.
Bernardi R; Papa A; Pandolfi PP
Oncogene; 2008 Oct; 27(48):6299-312. PubMed ID: 18931695
[TBL] [Abstract][Full Text] [Related]
4. PML control of cytokine signaling.
Maarifi G; Chelbi-Alix MK; Nisole S
Cytokine Growth Factor Rev; 2014 Oct; 25(5):551-61. PubMed ID: 24861946
[TBL] [Abstract][Full Text] [Related]
5. [A new player in PML-mediated cellular senescence: TBX2 gets into the loop].
Martin N; Dejean A; Bischof O
Med Sci (Paris); 2012 Mar; 28(3):248-50. PubMed ID: 22480643
[No Abstract] [Full Text] [Related]
6. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.
Quimby BB; Yong-Gonzalez V; Anan T; Strunnikov AV; Dasso M
Oncogene; 2006 May; 25(21):2999-3005. PubMed ID: 16501610
[TBL] [Abstract][Full Text] [Related]
7. Involvement of promyelocytic leukemia protein in the ethanol-induced apoptosis in mouse embryo fibroblasts.
Wang LH; Yang JY; Cui W; Shin YK; Wu CF
Yakugaku Zasshi; 2008 Jul; 128(7):1067-71. PubMed ID: 18591875
[TBL] [Abstract][Full Text] [Related]
8. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.
Zhang X; Yang XR; Sun C; Hu B; Sun YF; Huang XW; Wang Z; He YF; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J
Cancer Lett; 2015 Sep; 366(1):112-22. PubMed ID: 26118777
[TBL] [Abstract][Full Text] [Related]
9. Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.
Kuwayama K; Matsuzaki K; Mizobuchi Y; Mure H; Kitazato KT; Kageji T; Nakao M; Nagahiro S
Neuro Oncol; 2009 Apr; 11(2):132-41. PubMed ID: 18812519
[TBL] [Abstract][Full Text] [Related]
10. RXR is an essential component of the oncogenic PML/RARA complex in vivo.
Zhu J; Nasr R; Pérès L; Riaucoux-Lormière F; Honoré N; Berthier C; Kamashev D; Zhou J; Vitoux D; Lavau C; de Thé H
Cancer Cell; 2007 Jul; 12(1):23-35. PubMed ID: 17613434
[TBL] [Abstract][Full Text] [Related]
11. Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.
Xue Y; Li L; Zhang D; Wu K; Guo P; Zeng J; Wang X; He D
Oncol Rep; 2010 Dec; 24(6):1551-9. PubMed ID: 21042751
[TBL] [Abstract][Full Text] [Related]
12. The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.
Choi YH; Bernardi R; Pandolfi PP; Benveniste EN
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18715-20. PubMed ID: 17121994
[TBL] [Abstract][Full Text] [Related]
13. A role for cytoplasmic PML in cellular resistance to viral infection.
McNally BA; Trgovcich J; Maul GG; Liu Y; Zheng P
PLoS One; 2008 May; 3(5):e2277. PubMed ID: 18509536
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid attenuates promyelocytic leukemia protein-induced cell death in breast cancer cells by activation of the ubiquitin-proteasome pathway.
Son SH; Yu E; Ahn Y; Choi EK; Lee H; Choi J
Cancer Lett; 2007 Mar; 247(2):213-23. PubMed ID: 16740359
[TBL] [Abstract][Full Text] [Related]
15. Promyelocytic leukemia protein is required for gain of function by mutant p53.
Haupt S; di Agostino S; Mizrahi I; Alsheich-Bartok O; Voorhoeve M; Damalas A; Blandino G; Haupt Y
Cancer Res; 2009 Jun; 69(11):4818-26. PubMed ID: 19487292
[TBL] [Abstract][Full Text] [Related]
16. Neocortical neurogenesis and neuronal migration.
Tan X; Shi SH
Wiley Interdiscip Rev Dev Biol; 2013 Jul; 2(4):443-59. PubMed ID: 24014417
[TBL] [Abstract][Full Text] [Related]
17. A Prdm8 target gene Ebf3 regulates multipolar-to-bipolar transition in migrating neocortical cells.
Iwai R; Tabata H; Inoue M; Nomura KI; Okamoto T; Ichihashi M; Nagata KI; Mizutani KI
Biochem Biophys Res Commun; 2018 Jan; 495(1):388-394. PubMed ID: 29113800
[TBL] [Abstract][Full Text] [Related]
18. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.
Shima Y; Shima T; Chiba T; Irimura T; Pandolfi PP; Kitabayashi I
Mol Cell Biol; 2008 Dec; 28(23):7126-38. PubMed ID: 18809579
[TBL] [Abstract][Full Text] [Related]
19. PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML.
Kurahashi S; Hayakawa F; Miyata Y; Yasuda T; Minami Y; Tsuzuki S; Abe A; Naoe T
Oncogene; 2011 Apr; 30(15):1822-30. PubMed ID: 21217775
[TBL] [Abstract][Full Text] [Related]
20. PML tumor suppressor protein is required for HCV production.
Kuroki M; Ariumi Y; Hijikata M; Ikeda M; Dansako H; Wakita T; Shimotohno K; Kato N
Biochem Biophys Res Commun; 2013 Jan; 430(2):592-7. PubMed ID: 23219818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
